Florida Politics – Oct. 11
Florida Chief Financial Officer Jimmy Patronis is heading back to Tallahassee from Tampa after seeing his wife, Katie, through breast cancer surgery. The two were at Moffitt Cancer Center as Hurricane Michael ravaged the Florida Panhandle, including Panama City Beach where the couple and their children live.
Florida Observer – Oct. 11
Health fair partners include the Men’s Club of Sun City Center, SunTowers Retirement Community, Sun City Center Emergency Squad, South Bay Hospital, Moffitt Cancer Center and Tampa General Hospital.
WWSB – Oct. 11
All proceeds from this event benefit Moffitt Cancer Center and are dedicated to the advancement of treatment, awareness, and necessary research needed to understand the growing number of adrenal cancer cases ravaging our community.
PR Newswire – Oct. 11
Dr. Abate-Daga is an Assistant Member of the Department of Immunology at Moffitt. His group is interested in understanding how a new generation of immune receptors (Chimeric Antigen Receptors, conventional T-cell receptors, and others) can be designed to outperform the current products, in both antitumor efficacy and safety. Also posted to WFMJ, WENY, KITV and NewsBlaze.com.
Self Magazine – Oct. 9
The new recommendation means that you can get vaccinated even if you've already been sexually active (and have already potentially been exposed to some strains of HPV). That's because "it is unlikely that they were exposed to all nine types of HPV that the vaccine protects against,” Susan Vadaparampil, Ph.D., M.P.H., vice chair of the Health Outcomes and Behavior Department at Moffitt Cancer Center, tells SELF. “Thus, there are continued opportunities for health benefit from receiving the vaccine after age 27.”
Targeted Oncology – Oct. 9
In an interview with Targeted Oncology, Komrokji, principal investigator, MDS Research Consortium, Aplastic Anemia and MDS International Foundation, clinical director, Hematologic Malignancies, Moffitt Cancer Center, reflected on the diverse AML treatment landscape and touched on the prognostic importance of biomarkers.
Cure Today – Oct. 9
The Registry is sponsored by ALCF, the American Lung Association's LUNG FORCE and the International Association for the Study of Lung Cancer. SITC members Adam P. Dicker, MD, PhD (Thomas Jefferson University), and Heather S. Jim, PhD (H. Lee Moffitt Cancer Center & Research Institute), are leading the efforts on the subsequent patient study.
The ASCO Post – Oct. 9
The phase III PACIFIC trial showed significantly improved overall survival with durvalumab (Imfinzi) vs placebo after chemoradiotherapy in patients with unresectable stage III non–small cell lung cancer (NSCLC). Scott J. Antonia, MD, of the Moffitt Cancer Center, Tampa, Florida, reported these results at the International Association for the Study of Lung Cancer (IASCL) 19th World Conference on Lung Cancer held recently in Toronto. The findings were published simultaneously in The New England Journal of Medicine.
Targeted Oncology – Oct. 9
“We’ve cured 15% to 30% of patients [with stage III, unresectable NSCLC]. But of course, we’ve been stuck with those numbers for decades. We have not been able to make any inroads to improving the outcomes of these patients for quite some time,” said Antonia, department chair of the Thoracic Oncology Department at Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida College of Medicine.
Creative Loafing – Oct. 9
The Lobby Bar This new addition to the Epicurean Hotel features three beverages in support of Breast Cancer Awareness Month. Expect a local beer , a rosé and an original cocktail called the Pink Lady. Ten percent of the sales are donated to Moffitt Cancer Center. $8-$14. Through Oct. 31.
WICZ – Oct. 9
The meeting will include a brief company update from Scott Drake, President and Chief Executive Officer of ViewRay, followed by presentations from Louis B. Harrison, M.D., FASTRO, Chair and Senior Member, Department of Radiation Oncology at Moffitt Cancer Center and Michael L. Steinberg, M.D., Professor and Chair, Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. Also posted to WBOC and KAKE.
Patch – Oct. 9
Volunteers include Florida Hospital, the GFWC Temple Terrace Woman's Club, Moffitt Cancer Center, Florida College and USF's CERT Team.
Sun Sentinel – Oct. 9
Participants include research scientists and professors from the Max Planck Florida Institute for Neuroscience, Scripps Florida, Miami Leonard M. Miller School of Medicine, Moffitt Cancer Center, Florida Atlantic University, Nova Southeastern University and University of Central Florida.
MDLinx.com – Oct. 8
“Immune checkpoint inhibitors targeting programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) have shown activity in the treatment of numerous cancers, including advanced NSCLC,” wrote the authors, led by Scott J. Antonia, MD, PhD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
European Pharmaceutical Review – Oct. 8
Researchers from Harvard Chan School, along with colleagues from Brigham and Women’s Hospital in Boston and Moffitt Cancer Centre in Tampa, analyzed data on 205,498 women who were part of the Nurses’ Health Study and Nurses’ Health Study II. Of those, 1,054 developed ovarian cancer.
MedPage Today – Oct. 8
Co-author Jonathan Strosberg, MD, of Moffitt Cancer Center in Tampa, Florida, said a number of patients in the combination arm had changes in tumor status that did not meet criteria for objective response.
MedPage Today – Oct. 8
"After adjustment for other variables, receipt of surgery for stage IV patients showed a 71% decreased hazard of death," reported Benjamin D. Powers, MD, of Moffitt Cancer Center in Tampa, Florida, and colleagues at the North American Neuroendocrine Tumor Society annual symposium.
Tampa Bay Times – Oct. 5
"You really feel for the children (who have cancer) and the parents," said Tebbi, who, in collaboration with Moffitt, spends every weekday and some weekends, doing research toward the development of a vaccine to prevent leukemia.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.